$3.00
0.248.7%
Last update: Nov 6, 5:53 PM
Evaxion AS (EVAX) Stock Price, Quote, News & History
EVAXNASDAQ
Merck declines its option on Evaxion's EVX-B2 gonorrhea vaccine, leaving global rights with Evaxion and no change to its cash runway through 2027.
You can purchase shares of Evaxion (NASDAQ:EVAX) through any online brokerage.
Other companies in Evaxion’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Evaxion has a consensus price target of $11.25.
The stock price for Evaxion (NASDAQ: EVAX) is $2.92 last updated November 6, 2026 at 5:53 PM EST.
There are no upcoming dividends for Evaxion.
Evaxion does not have any upcoming earnings scheduled.
There is no upcoming split for Evaxion.
Evaxion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system...
